Genital herpes in women during and outside of pregnancy
https://doi.org/10.21518/2079-701X-2018-13-61-64
Abstract
Annually, about 500 thousand people get new genital herpes (GH) infections. The incidence of GH in Russia was 13.5 cases per 100 thousand people in 2015. According to the WHO (2015), 67% of population is infected with herpes simplex virus. The numerous studies in general population showed that women were infected more often than men with the same number of sexual partners during life, and the highest incidence of GH was recorded in the age group between 20 and 29 years, and the second peak incidence was recorded at the age of 35–40 years [1–3].
About the Authors
S. V. Pavlovich
Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology of the Ministry of Health of Russia;
Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)
Russian Federation
Moscow
Russian Federation
Moscow
N. M. Nazarova
Kulakov National Medical Research Centre for Obstetrics, Gynaecology and Perinatology of the Ministry of Health of Russia
Russian Federation
Moscow
Russian Federation
Moscow
References
1. WHO document. The Global Strategy for the Prevention and Control of Sexually Transmitted Infections 2006-2015 M., 2007.
2. WHO. Fact sheet. 2013, 110
3. Resources and activities of medical dermatological organizations. Incidence of sexually transmitted infections, contagious skin diseases and skin diseases (statistical materials). M., 2016, p. 99, www.mednet.ru.
4. Modi S, Van L, Gewirtzman A et al. Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology. Ther Clin Ris Man, 2008, 4(2): 409–417.
5. Bartlett BL, Tyring SK, Fife K et al. Famciclovir treatment options for pa- tients with frequent outbreaks of recurrent genital herpes: The RELIEF trial. J ClinVirol, 2008, 43: 190–195.
6. Marchenko LA, Lushkova IP, Shurshalina AV. Treatment of patients with recurrent genital herpes. Vopr. Gin. Acush. I Perinatologii, 2004, 6: 90-93.
7. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidencebased review. Arch Int Med, 2008, 168(11): 1137–1144.
8. CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep, 2015, 64(3): 27–32.
9. Federal clinical guidelines. Dermatovenereology. 2015. Skin diseases. Sexually transmitted infections. 5th Ed., revised and enlarged. M.: Delovoi Express, 2016. p. 655-664.
10. Patel R, Alderson S, Geretti A, et al. European guidelines for the management of patients with genital herpes (2010). Effektivnaya Farmakoterapiya (Akusherstvo i Ginekologiya). 2012, 2: 4-15.
11. Management of patients with sexually transmitted infections and urogenital infections. Klin.Rekomendatsii. M., 2012: 20-24.
12. Shurshalina AV, Krechetova LV, Ziganshina MM, Sukhikh GT. Local effect of epigen intim spray (glycyrrhizic acid) in viral infections of genital organs. Akusherstvo i Ginekologiya, 2009, 3: 1-4.
13. Kuzmin VN. Modern view on the clinical course, diagnosis and therapy of genital herpes in women. Lechashchii Vrach, 2009, 3: 42-47.
14. Sexually Transmitted Diseases Treatment Guidelines. Cent Dis Control Prev, 2010, 20–25.
15. Bulgakova VP. Evaluation of the effectiveness of the use of epigen in the complex pre-conceptional training of women with recurrent genital herpes. Rossiyskiy Vestnik Akushera-Ginekologa, 2010, 3: 46-55.
16. Bashmakova NV, Motornuk YuI, Zilber NA. Problems of diagnosis and therapy of genital herpes during pregnancy (preliminary report). Rossiyskiy vestnik akushera-ginekologa. 2007, 5: 71-74.
17. Shevtsova EP, Krasilnikova MO, Zhebrun EV, Mysgin AV. Experience in using Epigen intim spray in obstetric practice. Remedium-Privolzhye, 2005
Review
For citations:
Pavlovich SV, Nazarova NM. Genital herpes in women during and outside of pregnancy. Meditsinskiy sovet = Medical Council. 2018;(13):61-64. (In Russ.) https://doi.org/10.21518/2079-701X-2018-13-61-64
Views:
859
Email this article 